305 related articles for article (PubMed ID: 12023853)
1. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis.
Howell DC; Laurent GJ; Chambers RC
Biochem Soc Trans; 2002 Apr; 30(2):211-6. PubMed ID: 12023853
[TBL] [Abstract][Full Text] [Related]
2. Coagulation cascade proteases and tissue fibrosis.
Chambers RC; Laurent GJ
Biochem Soc Trans; 2002 Apr; 30(2):194-200. PubMed ID: 12023850
[TBL] [Abstract][Full Text] [Related]
3. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
Howell DC; Goldsack NR; Marshall RP; McAnulty RJ; Starke R; Purdy G; Laurent GJ; Chambers RC
Am J Pathol; 2001 Oct; 159(4):1383-95. PubMed ID: 11583966
[TBL] [Abstract][Full Text] [Related]
4. Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis.
Kijiyama N; Ueno H; Sugimoto I; Sasaguri Y; Yatera K; Kido M; Gabazza EC; Suzuki K; Hashimoto E; Takeya H
Biochem Biophys Res Commun; 2006 Jan; 339(4):1113-9. PubMed ID: 16338226
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
6. Role of coagulation and fibrinolysis in lung and renal fibrosis.
Ruppert C; Markart P; Wygrecka M; Preissner KT; Günther A
Hamostaseologie; 2008 Feb; 28(1-2):30-2, 34-6. PubMed ID: 18278159
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
Sriram N; Kalayarasan S; Sudhandiran G
Chem Biol Interact; 2009 Jul; 180(2):271-80. PubMed ID: 19497426
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor-dependent coagulation protease signaling in acute lung injury.
Ruf W; Riewald M
Crit Care Med; 2003 Apr; 31(4 Suppl):S231-7. PubMed ID: 12682445
[TBL] [Abstract][Full Text] [Related]
9. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis.
Lucey EC; Ngo HQ; Agarwal A; Smith BD; Snider GL; Goldstein RH
Lab Invest; 1996 Jan; 74(1):12-20. PubMed ID: 8569173
[TBL] [Abstract][Full Text] [Related]
11. Significance of thrombin in bleomycin-induced pulmonary fibrosis.
Tani K; Yasuoka S; Ogura T
Tokushima J Exp Med; 1990 Jun; 37(1-2):39-48. PubMed ID: 1701928
[TBL] [Abstract][Full Text] [Related]
12. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
13. Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2.
Kalayarasan S; Sriram N; Soumyakrishnan S; Sudhandiran G
Toxicol Appl Pharmacol; 2013 Sep; 271(2):184-95. PubMed ID: 23656969
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
15. [The role of thrombin on lung fibroblast growth and fibrosis in bleomycin-induced lung disorder].
Tani K; Yasuoka S; Ogushi F; Asada K; Fujisawa K; Ozaki T; Ogura T; Suzuki K
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):211-9. PubMed ID: 1709710
[TBL] [Abstract][Full Text] [Related]
16. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
17. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
Howell DC; Johns RH; Lasky JA; Shan B; Scotton CJ; Laurent GJ; Chambers RC
Am J Pathol; 2005 May; 166(5):1353-65. PubMed ID: 15855637
[TBL] [Abstract][Full Text] [Related]
18. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
19. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
